Vaccine could wipe out recurring breast cancer

AN EXPERIMENTAL breast cancer vaccine has the potential to wipe out resistant and recurring tumours in many women, say researchers.

The treatment would be tailored to women with HER2-positive cancers, which account for up to 30% of all cases and tend to be highly aggressive.

In mice, HER2-positive tumours were completely eliminated by the vaccine with no evidence of toxicity.